Minnesota FOIA #H009440401

Optimized Production and Validation of Rationally Designed AAV Vectors for Cockayne Syndrome Gene Therapy

The Twin Cities government agency issued a purchase order to Mayo Clinic for the optimized production and validation of rationally designed AAV vectors for Cockayne Syndrome gene therapy, with an obligated amount of $90,000. The award was made on October 13, 2021, and is a single-transaction contract. The vendor, Mayo Clinic, is located in Minneapolis, MN, USA, and the purchase involves a single lot of the specified gene therapy product. The procurement appears to be for a research or medical purpose, with no mention of multi-year or blanket arrangements. The likely competitors for similar awards could include other major medical research institutions or biotech firms involved in gene therapy development.

Description

Optimized Production and Validation of Rationally Designed AAV Vectors for Cockayne Syndrome Gene Therapy